Blog
RSS FeedPosted by Michael Wonder on 24 Jan 2025
Australia’s TGA approves registration of CSL’s Andembry (garadacimab) for the prevention of recurrent hereditary angioedema attacks
24 January 2025 - This regulatory approval for registration in Australia is the first in the world for Andembry. ...
Posted by Michael Wonder on 21 Jan 2025
Drug shortage crisis demands intervention, AMA warns, as patients struggle to secure medicines
20 January 2025 - There are more than 400 medicine shortages, and the country’s leading medical group blames it on ‘ad ...
Posted by Michael Wonder on 20 Jan 2025
Australians benefit from freeze to maximum cost of PBS medicines
20 January 2025 - The Australian Government has launched an advertising campaign to raise awareness about a freeze on the maximum ...
Posted by Michael Wonder on 19 Jan 2025
Protection against RSV for mums and bubs with free vaccine available from 3 February
19 January 2025 - From 3 February 2025, Australian mums and their newborn babies will have free access to the best ...
Posted by Michael Wonder on 19 Jan 2025
Junshi Biosciences announces toripalimab’s approval in Australia
17 January 2025 - Shanghai Junshi Biosciences announced that toripalimab, the anti-PD-1 monoclonal antibody self-developed by the company, has obtained the ...
Posted by Michael Wonder on 13 Jan 2025
Peter’s prostate cancer diagnosis came as a shock. Now, he wants to protect his kids.
14 January 2025 - Peter had no symptoms when he was diagnosed with prostate cancer. Now, he’d like to see an ...
Posted by Michael Wonder on 06 Jan 2025
Price must be right to put obesity pill on the PBS
6 January 2025 - Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for ...
Posted by Michael Wonder on 06 Jan 2025
Global pharma giants push for weight loss drugs to be added to PBS
6 January 2025 - Taxpayers would fund popular weight loss drugs for people with severe obesity under a proposal from ...
Posted by Michael Wonder on 02 Jan 2025
Cheaper medicines stay cheaper as Australians save $1.1 billion
2 January 2025 - On 1 January 2025, for the first time in more than 25 years, the maximum amount people ...
Posted by Michael Wonder on 02 Jan 2025
New and expanded PBS listings for breast and prostate cancer
2 January 2025 - Australians with prostate and breast cancer now have affordable access to affordable new and expanded medicines ...
Posted by Michael Wonder on 01 Jan 2025
Schedule of Pharmaceutical Benefits - 1 January 2025
1 January 2025 - The January 2025 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 28 Dec 2024
Utilisation analysis of heart failure medicines listed on the PBS
20 December 2024 - At its September 2024 meeting, the PBAC considered a report presenting a utilisation analysis of PBS ...
Posted by Michael Wonder on 27 Dec 2024
Labor leaves genetics loophole for life insurers
21 December 2024 - One of the last barriers to widespread genetic testing — discrimination against obtaining life insurance — ...
Posted by Michael Wonder on 27 Dec 2024
Bureaucratic ‘deficiencies’ in medicine funding underscore access crisis
26 December 2024 - The Government’s independent medicine funding assessor, still recovering from a public failure to process months worth ...
Posted by Michael Wonder on 26 Dec 2024
PBS Expenditure and Prescriptions Report (2023-24)
19 December 2024 - The PBS Expenditure and Prescriptions Report 1 July 2023 to 30 June 2024 is now available. ...